Status:

COMPLETED

Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis

Lead Sponsor:

Deutsches Herzzentrum Muenchen

Conditions:

Heart Disease

Ischemia

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose of this randomized study is to determine which treatment option, either paclitaxel-eluting balloon, paclitaxel-eluting stent or plain balloon angioplasty is the most effective in the treat...

Detailed Description

The use of drug-eluting stents (DES) has led to a drastic reduction of restenosis rates compared to bare metal stents (BMS), but 5% to 10% of patients receiving DES are still in need of revascularizat...

Eligibility Criteria

Inclusion

  • Patients with ischemic symptoms or evidence of myocardial ischemia in the presence of ≥ 50% restenosis after prior implantation of LES in native coronary vessels.
  • Written, informed consent by the patient or her/his legally-authorized representative for participation in the study.
  • In women with childbearing potential a negative pregnancy test is mandatory.

Exclusion

  • Age \< 18 years.
  • Cardiogenic shock.
  • Acute ST-elevation myocardial infarction within 48 hours from symptom onset.
  • Target lesion located in the left main trunk or bypass graft.
  • Target lesion located in small vessel (vessel size \< 2.0 mm).
  • Malignancies or other comorbid conditions (for example severe liver, renal and pancreatic disease) with life expectancy less than 12 months or that may result in protocol non-compliance.
  • Severe renal insufficiency (glomerular filtration rate ≤ 30 ml/min).
  • Contraindications to antiplatelet therapy, paclitaxel, stainless steel, cobalt, chrome.
  • Pregnancy (present, suspected or planned) or positive pregnancy test.
  • Previous enrollment in this trial.
  • Patient's inability to fully comply with the study protocol.

Key Trial Info

Start Date :

July 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2013

Estimated Enrollment :

402 Patients enrolled

Trial Details

Trial ID

NCT00987324

Start Date

July 1 2009

End Date

October 1 2013

Last Update

November 21 2016

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

1. Med. Klinik, Klinikum rechts der Isar

Munich, Bavaria, Germany, 81675

2

Herz-Zentrum

Bad Krozingen, Germany, 79189

3

Deutsches Herzzentrum

Munich, Germany, 80636

Efficacy Study of Paclitaxel-eluting Balloon, -Stent vs. Plain Angioplasty for Drug-eluting Stent Restenosis | DecenTrialz